DoubleLine ETF Adviser LP cut its stake in The Clorox Company (NYSE:CLX – Free Report) by 3.4% in the second quarter, Holdings Channel reports. The firm owned 5,149 shares of the company’s stock after selling 181 shares during the period. DoubleLine ETF Adviser LP’s holdings in Clorox were worth $703,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the stock. CIBC Private Wealth Group LLC boosted its stake in Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after purchasing an additional 66 shares in the last quarter. Lindbrook Capital LLC boosted its stake in Clorox by 6.2% in the 1st quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after purchasing an additional 69 shares in the last quarter. Fiduciary Group LLC boosted its stake in Clorox by 0.4% in the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after purchasing an additional 72 shares in the last quarter. GHP Investment Advisors Inc. boosted its stake in Clorox by 2.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after purchasing an additional 72 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. boosted its stake in Clorox by 5.1% in the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock worth $233,000 after purchasing an additional 83 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Clorox
In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.51% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on CLX
Clorox Price Performance
NYSE:CLX opened at $161.91 on Friday. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The firm has a market cap of $20.11 billion, a price-to-earnings ratio of 83.89, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40. The company has a 50 day moving average price of $150.84 and a 200-day moving average price of $143.96. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.09.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. Equities research analysts forecast that The Clorox Company will post 6.63 EPS for the current year.
Clorox Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.01%. Clorox’s dividend payout ratio is currently 252.85%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- 3 Warren Buffett Stocks to Buy Now
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Options Trading – Understanding Strike Price
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.